 | DVLA - Darya-Varia Laboratoria Tbk. | DVLA - Darya-Varia Laboratoria Tbk. | DVLA - Darya-Varia Laboratoria Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (5) | : | COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Index (5) | : | COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Board | : | 5 Index COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | |
|||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 5 | |
| Rating ROA | 3 | |
| Rating EQUITY | 2 | |
| Rating ROE | 3 | |
| Rating DER | 4 | |
| Rating TOTAL | 4 | |
| MARKET CAPITALIZATION | ||
| Listed Share | 1.120.000.000 | |
| Price | Rp. 1.630 | |
| Capitalization | Rp. 1.825.600.000.000 | |
| OWNERSHIP | ||
| Listing Date : | ||
| Lokal 2,71 % | Asing 97,17 % | Lainnya 0,12 % |
| DVLA - Darya-Varia Laboratoria Tbk. | DVLA - Darya-Varia Laboratoria Tbk. | DVLA - Darya-Varia Laboratoria Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (5) | : | COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Index (5) | : | COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Board | : | 5 Index COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
Financial Statements
| Description | 3Q18 | 3Q19 | 3Q20 | 3Q21 | 3Q22 | 3Q23 | 3Q24 | CAGR 5Y(%) |
| Last Price | 1930 | 2210 | 2520 | 2450 | 2500 | 1995 | 1810 | |
| Market Cap | 2.2 T | 2.5 T | 2.8 T | 2.7 T | 2.8 T | 2.2 T | 2.0 T | -20.00 |
| BALANCE SHEET | ||||||||
| Cash | 347.5 B | 334.2 B | 364.3 B | 421.5 B | 384.5 B | 341.0 B | 437.9 B | 31.03 |
| Total Asset | 1.7 T | 1.9 T | 1.9 T | 2.2 T | 2.1 T | 2.0 T | 2.3 T | 21.05 |
| S.T.Borrowing | 390.5 B | 460.8 B | 419.8 B | 542.3 B | 481.1 B | 443.7 B | 610.4 B | |
| L.T.Borrowing | 102.3 B | 101.0 B | 133.7 B | 137.1 B | 141.1 B | 150.7 B | 163.7 B | |
| Total Equity | 1.2 T | 1.3 T | 1.4 T | 1.5 T | 1.5 T | 1.4 T | 1.5 T | 15.38 |
| INCOME STATEMENT | ||||||||
| Revenue | 1.2 T | 1.4 T | 1.3 T | 1.6 T | 1.5 T | 1.3 T | 1.6 T | 14.29 |
| Gross Profit | 676.2 B | 768.9 B | 659.7 B | 837.9 B | 813.8 B | 688.3 B | 837.9 B | 8.97 |
| Operating Profit | 217.4 B | 236.9 B | 189.5 B | 343.4 B | 208.3 B | 129.7 B | 194.7 B | -17.81 |
| Net.Profit | 163.2 B | 177.6 B | 147.3 B | 268.1 B | 165.3 B | 99.8 B | 147.4 B | -17.00 |
| EBITDA | 235.7 B | 256.8 B | 213.3 B | 370.0 B | 235.2 B | 155.1 B | 221.7 B | -13.67 |
| Interest Expense | 1.1 B | 44.1 M | 21.0 M | 174.4 M | 52.8 M | 40.1 M | ||
| RATIO | ||||||||
| EPS | 148.4 | 161.43 | 133.9 | 243.69 | 150.27 | 90.74 | 133.99 | -17.00 |
| PER | 13.01 x | 13.69 x | 18.82 x | 10.05 x | 16.64 x | 21.98 x | 13.51 x | |
| BVPS | 1073.97 | 1154.31 | 1209.65 | 1341.08 | 1300.03 | 1261.86 | 1318.69 | |
| PBV | 1.80 x | 1.91 x | 2.08 x | 1.83 x | 1.92 x | 1.58 x | 1.37 x | |
| ROA | 0.0963 | 0.0957 | 0.0772 | 0.1229 | 0.0795 | 0.0497 | 0.0655 | -31.56 |
| ROE | 0.1357 | 0.1374 | 0.1087 | 0.1785 | 0.1135 | 0.0706 | 0.0998 | -27.37 |
| EV/EBITDA | 9.79 | 10.52 | 14.12 | 8.11 | 12.92 | 16.04 | 10.66 | |
| Debt/Equity | 0.41 | 0.43 | 0.41 | 0.45 | 0.43 | 0.42 | 0.52 | |
| Debt/TotalCap | 0.29 | 0.3 | 0.29 | 0.31 | 0.3 | 0.3 | 0.34 | |
| Debt/EBITDA | 2.09 | 2.19 | 2.6 | 1.84 | 2.65 | 3.83 | 3.49 | |
| EBITDA/IntExps | 206.55 | 4835.2 | 17588.56 | 1348.6 | 2939.09 | 5523.73 | 14.24 | |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | |
|||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| MARKET CAPITALIZATION | ||
| Listed Share | 1.120.000.000 | |
| Price | Rp. 1.630 | |
| Capitalization | Rp. 1.826 B. | |
| OWNERSHIP | ||
| Listing Date : | ||
| Lokal 2,71 % | Asing 97,17 % | Lainnya 0,12 % |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 5 | |
| Rating ROA | 3 | |
| Rating EQUITY | 2 | |
| Rating ROE | 3 | |
| Rating DER | 4 | |
| Rating TOTAL | 4 | |
RETURN ON ASSET
| DVLA - Darya-Varia Laboratoria Tbk. | DVLA - Darya-Varia Laboratoria Tbk. | DVLA - Darya-Varia Laboratoria Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (5) | : | COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Index (5) | : | COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Board | : | 5 Index COMPOSITE, IDXHEALTH, DBX, ISSI, IDXSMC-COM | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| TIME PERIOD : 29-11-2024 | |||
| Close | 1630 | Prev Close | 1640 |
| Change | -10 (-0.6%) | Range | 1625-1665 |
| Bid | 1630 | Offer | 1645 |
| Bid Volume | 12600 | Offer Volume | 900 |
| Frequency | 21 | Value Rp.: 14.735.500 | |
| RETURN ON ASSET | |||||
|---|---|---|---|---|---|
| Benchmark to Others : | |||||
| A Exceptional | |||||
| B Excellent | |
||||
| C Very Good | |||||
| D Good | |||||
| E Fair | |||||
| F Poor | |||||
| RATIO (%) | ≤ 0 |
0-0.4 | 0.4- 1.7 |
1.7- 3.6 |
> 3.6 |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | |
|||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |